Report- Autoimmune-Disease-Therapeutics-Market-Report-2017 | Page 6

(2012-2017)
10.10.4 Main Business/Business Overview
10.11 Sanofi
11 Autoimmune Disease Therapeutics Manufacturing Cost Analysis
11.1 Autoimmune Disease Therapeutics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Autoimmune Disease Therapeutics
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Autoimmune Disease Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Autoimmune Disease Therapeutics Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Autoimmune Disease Therapeutics Market Forecast (2017-2022)
14.1 Germany Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.2 France Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.3 UK Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.4 Russia Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.5 Italy Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.6 Spain Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.7 Benelux Autoimmune Disease Therapeutics Sales Forecast (2017-2022)
14.8 Europe Autoimmune Disease Therapeutics Sales Forecast by Type (2017-2022)
14.9 Europe Autoimmune Disease Therapeutics Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source